查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1773766

多重免疫測量市場：全球產業分析、市場規模、佔有率、成長、趨勢和未來預測（2025-2032年）

Multiplex Detection Immunoassay Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 199 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球多重檢測免疫測量市場的全面分析報告。本報告對重要市場動態進行了全面評估，包括市場促進因素、趨勢、機會和挑戰，並深入分析了市場結構。報告提供了獨家資料和統計資料，概述了全球多重檢測免疫測量市場的預測成長軌跡（2025-2032年）。

關鍵見解

  • 多重免疫測量市場規模（2025年）：32億美元
  • 市場規模預測（以金額為準，2032年）：44億美元
  • 全球市場成長率（2025-2032年年複合成長率）：4.4%

多重檢測免疫測量市場－分析範圍

多重檢測免疫測量市場是指能夠在單次檢測中同時檢測和定量多種生物標記的先進診斷技術。這些檢測方法在疾病診斷、藥物研發和生物醫學研究中非常重要，具有高通量、低試劑成本和快速獲得結果等優勢。慢性病和感染疾病的日益流行，加上對早期診斷和精準醫療的重視，推動臨床和研究領域對多重檢測技術的需求。

市場成長動力：

由於癌症、自體免疫疾病和感染疾病等需要高階診斷的慢性疾病的增多，全球多重檢測免疫測量市場正經歷強勁成長。對經濟高效、高通量篩檢工具的需求，推動了多重檢測在臨床和研究環境中的應用。此外，個人化醫療的轉變以及對高效藥物開發流程的需求，加速多重檢測技術的應用。研發資金的增加以及製藥公司和診斷公司之間日益加強的合作，也大大促進了市場的擴張。

市場限制：

儘管多重檢測免疫測量市場具有顯著優勢，但也面臨許多限制因素。高昂的初始投資成本和檢測方法開發的複雜性可能會阻礙其應用，尤其是在小型實驗室和新興經濟體中。交叉反應和跨平台標準化程度有限等技術挑戰可能會影響檢測的準確性和可重複性。此外，多重檢測的核准和商業化相關的監管障礙增加了新參與企業的市場准入難度，抑制了整體成長。

市場機會：

多重檢測免疫測量市場蘊含著龐大的商機，尤其是在檢測設計、微流體和自動化技術不斷進步的背景下。向醫療基礎設施快速發展的南美、拉丁美洲和非洲等新興市場擴張，代表著一條充滿希望的成長途徑。多重檢測平台在藥物開發和生物標記檢驗的應用日益增多，為診斷和生物技術公司帶來了豐厚的前景。策略夥伴關係、持續創新以及將人工智慧和資料分析融入檢測解讀，預計將在未來幾年創造競爭優勢並開闢新的應用領域。

本報告回答的關鍵問題

  • 推動多重檢測免疫測量市場成長的主要因素有哪些？
  • 預測期內哪些技術和應用領域可望佔據領先地位？
  • 個人化醫療等醫療保健趨勢如何影響市場需求？
  • 全球多重檢測免疫測量市場的主要企業有哪些？他們採用了哪些策略？
  • 各地區的成長預測如何？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 限制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長前景
  • COVID-19影響分析
  • 預測因子－相關性和影響力

第3章 加值分析

  • 產品採用分析
  • 監管狀況
  • 價值鏈分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第4章 定價分析（2025年）

  • 主要亮點
  • 影響產品價格的關鍵因素
  • 依產品進行價格分析
  • 區域價格和產品偏好

第5章 全球多重免疫測量市場展望

  • 主要亮點
    • 市場規模預測（以數量為基礎）
    • 市場規模及年成長率（以金額為準）
    • 絕對的商機
  • 市場規模分析與預測（以金額為準）
    • 歷史市場規模分析（以金額為準，2019-2024）
    • 當前市場規模分析與預測（以金額為準，2025-2032）
  • 全球多重檢測免疫測量市場展望：依產品
    • 引言/主要發現
    • 歷史市場規模分析：依產品（價值與數量基礎，2019-2024年）
    • 市場規模分析和預測：依產品（價值和數量基礎，2025-2032年）
      • 裝置
      • 套件和試劑
      • 軟體與服務
    • 市場吸引力分析：依產品
  • 全球多重免疫測量市場展望：依方法
    • 引言/主要發現
    • 歷史市場規模分析：依方法（價值和數量，2019-2024）
    • 市場規模分析和預測：依方法（價值和數量基礎，2025-2032年）
      • 核酸多重檢測
      • 蛋白質多重檢測
      • 基於細胞的多重分析
    • 市場吸引力分析：依方法
  • 全球多重檢測免疫測量市場展望：依技術
    • 引言/主要發現
    • 歷史市場規模分析：依技術（價值和數量基礎，2019-2024年）
    • 市場規模分析和預測：依技術（價值和數量，2025-2032）
      • 流式細胞技術
      • 以微珠為基礎的多重檢測
      • 照明
      • 多重即時PCR
      • 其他
    • 市場吸引力分析：依技術
  • 全球多重檢測免疫測量市場展望：依應用
    • 引言/主要發現
    • 歷史市場規模分析：依應用（價值和數量基礎，2019-2024年）
    • 市場規模分析和預測：依應用（價值和數量基礎，2025-2032年）
      • 疾病診斷
      • 研究與開發
      • 藥物研發
      • 其他
    • 市場吸引力分析：依應用
  • 全球多重檢測免疫測量市場前景：依最終用戶
    • 引言/主要發現
    • 歷史市場規模分析：依最終用戶（價值和數量基礎，2019-2024年）
    • 市場規模分析和預測：依最終用戶（價值和數量基礎，2025-2032）
      • 製藥和生物技術公司
      • CRO（委外研發機構）
      • 學術研究所
      • 診斷與參考實驗室
      • 其他
    • 市場吸引力分析：依最終用戶

第6章 全球多重檢測免疫測量市場展望：依地區

  • 主要亮點
  • 歷史市場規模分析：依地區（價值和數量基礎，2019-2024年）
  • 市場規模分析和預測：依地區（價值和數量基礎，2025-2032年）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：依地區

第7章 北美多重免疫測量市場展望

第8章 歐洲多重免疫測量市場展望

第9章 東亞多重免疫測量市場展望

第10章 南亞和大洋洲多重檢測免疫測量市場展望

第11章 拉丁美洲多重免疫測量市場展望

第12章 中東和非洲多重免疫測量市場展望

第13章 競爭格局

  • 市場佔有率分析（2025年）
  • 市場結構
    • 競爭強度圖：依市場
    • 競爭儀錶板
  • 公司簡介（詳情：概述、財務狀況、策略、最新發展）
    • Meridian Bioscience
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • QIAGEN
    • Bio-Techne
    • DiaSorin SpA
    • BIOMERIEUX
    • Quanterix
    • Randox Laboratories Ltd.
    • Merck KGaA
    • Revvity
    • F. Hoffmann-La Roche Ltd
    • Sartorius AG
    • Seegene Inc.
    • BioGenex
    • Miltenyi Biotec
    • SouthernBiotech
    • Healgen
    • Sepmag
    • Curiox Biosystems
    • MESO SCALE DIAGNOSTICS, LLC
    • Wuxi NEST Biotechnology Co.,Ltd

第14章 附錄

  • 分析方法
  • 分析假設
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP11542

Persistence Market Research has recently released a comprehensive report on the global Multiplex Detection Immunoassay Market, offering an in-depth evaluation of market dynamics, including key growth drivers, restraints, opportunities, and emerging trends. This report serves as a valuable resource for industry stakeholders, providing insights into market potential, competitive landscape, and strategic recommendations for future growth.

Key Insights:

  • Multiplex Detection Immunoassay Market Size (2025E): US$ 3.2 Bn
  • Projected Market Value (2032F): US$ 4.4 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.4%

Multiplex Detection Immunoassay Market - Report Scope:

The multiplex detection immunoassay market refers to advanced diagnostic technologies that allow simultaneous detection and quantification of multiple biomarkers in a single assay. These assays are crucial in disease diagnostics, drug discovery, and biomedical research, offering high throughput, reduced reagent costs, and faster results. Growing prevalence of chronic and infectious diseases, combined with increased emphasis on early diagnosis and precision medicine, is enhancing the demand for multiplex technologies across clinical and research settings.

Market Growth Drivers:

The global multiplex detection immunoassay market is experiencing robust growth driven by rising incidences of chronic illnesses such as cancer, autoimmune diseases, and infectious conditions that require advanced diagnostics. The demand for cost-effective and high-throughput screening tools has propelled the adoption of multiplex assays in both clinical and research environments. Additionally, the shift towards personalized medicine and the need for efficient drug development processes are accelerating the use of multiplex technologies. Increased funding for R&D and growing collaborations between pharmaceutical companies and diagnostics firms are also contributing significantly to market expansion.

Market Restraints:

Despite its significant advantages, the multiplex detection immunoassay market faces several limitations. High initial investment costs and the complexity of assay development may hinder adoption, particularly among smaller laboratories and emerging economies. Technical challenges such as cross-reactivity and limited standardization across platforms can affect assay accuracy and reproducibility. Furthermore, regulatory hurdles associated with multiplex assay approval and commercialization add to the complexity of market entry for new players, restraining overall growth.

Market Opportunities:

The multiplex detection immunoassay market holds substantial opportunities, especially with technological advancements in assay design, microfluidics, and automation. Expansion into emerging markets such as South Asia, Latin America, and Africa, where healthcare infrastructure is rapidly evolving, provides a promising growth avenue. The increasing use of multiplex platforms in drug development and biomarker validation offers lucrative prospects for diagnostic and biotech firms. Strategic partnerships, continuous innovation, and the integration of AI and data analytics into assay interpretation are expected to create competitive advantages and unlock new application areas in the coming years.

Key Questions Answered in the Report:

  • What are the main factors driving growth in the multiplex detection immunoassay market?
  • Which technology and application segments are expected to lead during the forecast period?
  • How are healthcare trends such as personalized medicine influencing market demand?
  • Who are the key players in the global multiplex immunoassay space and what strategies are they adopting?
  • What is the projected growth across different geographic regions?

Competitive Intelligence and Business Strategy:

Leading companies in the multiplex detection immunoassay market, such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, QIAGEN, and Merck KGaA, are focusing on R&D investments and product innovation to enhance assay sensitivity and flexibility. Strategic collaborations with CROs and pharmaceutical companies are enabling better integration of multiplex assays in clinical trials and drug discovery pipelines. Furthermore, companies are expanding their global footprint through acquisitions, distribution partnerships, and entry into high-growth emerging markets. Emphasis on automation, miniaturization, and digital data analysis is further enhancing their competitive positioning.

Companies Covered in This Report:

  • Meridian Bioscience
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • QIAGEN
  • Bio-Techne
  • DiaSorin S.p.A.
  • BIOMERIEUX
  • Quanterix
  • Randox Laboratories Ltd.
  • Merck KGaA
  • Revvity
  • F. Hoffmann-La Roche Ltd
  • Sartorius AG
  • Seegene Inc.
  • BioGenex
  • Miltenyi Biotec

Market Segmentation:

By Product:

  • Instruments
  • Kits & Reagents
  • Software & Services

By Technique:

  • Nucleic Acid Multiplex Assays
  • Protein Multiplex Assays
  • Cell-Based Multiplex Assays

By Technology:

  • Flow Cytometry
  • Multiplex Bead-Based Assay
  • Luminescence
  • Multiplex Real-Time PCR
  • Others

By Application:

  • Disease Diagnostics
  • Research & Development
  • Drug Discovery & Development
  • Others

By End User:

  • Pharmaceutical & Biotech Companies
  • Clinical Research Organizations (CROs)
  • Academic Research Institutes
  • Diagnostic and Reference Laboratories
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Multiplex Detection Immunoassay Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2025A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Multiplex Detection Immunoassay Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Multiplex Detection Immunoassay Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Instruments
      • 5.3.3.2. Kits & Reagents
      • 5.3.3.3. Software & Services
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Multiplex Detection Immunoassay Market Outlook: Technique
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Technique, 2019-2024
    • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
      • 5.4.3.1. Nucleic Acid Multiplex Assays
      • 5.4.3.2. Protein Multiplex Assays
      • 5.4.3.3. Cell-Based Multiplex Assays
    • 5.4.4. Market Attractiveness Analysis: Technique
  • 5.5. Global Multiplex Detection Immunoassay Market Outlook: Technology
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2024
    • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
      • 5.5.3.1. Flow Cytometry
      • 5.5.3.2. Multiplex Bead-Based Assay
      • 5.5.3.3. Luminescence
      • 5.5.3.4. Multiplex Real-Time PCR
      • 5.5.3.5. Others
    • 5.5.4. Market Attractiveness Analysis: Technology
  • 5.6. Global Multiplex Detection Immunoassay Market Outlook: Application
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 5.6.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.6.3.1. Disease Diagnostics
      • 5.6.3.2. Research & Development
      • 5.6.3.3. Drug Discovery & Development
      • 5.6.3.4. Others
    • 5.6.4. Market Attractiveness Analysis: Application
  • 5.7. Global Multiplex Detection Immunoassay Market Outlook: End User
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 5.7.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.7.3.1. Pharmaceutical & Biotech Companies
      • 5.7.3.2. Clinical Research Organizations (CROs)
      • 5.7.3.3. Academic Research Institutes
      • 5.7.3.4. Diagnostic and Reference Laboratories
      • 5.7.3.5. Others
    • 5.7.4. Market Attractiveness Analysis: End User

6. Global Multiplex Detection Immunoassay Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Multiplex Detection Immunoassay Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Technique
    • 7.2.4. By Technology
    • 7.2.5. By Application
    • 7.2.6. By End User
  • 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Instruments
    • 7.4.2. Kits & Reagents
    • 7.4.3. Software & Services
  • 7.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 7.5.1. Nucleic Acid Multiplex Assays
    • 7.5.2. Protein Multiplex Assays
    • 7.5.3. Cell-Based Multiplex Assays
  • 7.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 7.6.1. Flow Cytometry
    • 7.6.2. Multiplex Bead-Based Assay
    • 7.6.3. Luminescence
    • 7.6.4. Multiplex Real-Time PCR
    • 7.6.5. Others
  • 7.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.7.1. Disease Diagnostics
    • 7.7.2. Research & Development
    • 7.7.3. Drug Discovery & Development
    • 7.7.4. Others
  • 7.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.8.1. Pharmaceutical & Biotech Companies
    • 7.8.2. Clinical Research Organizations (CROs)
    • 7.8.3. Academic Research Institutes
    • 7.8.4. Diagnostic and Reference Laboratories
    • 7.8.5. Others
  • 7.9. Market Attractiveness Analysis

8. Europe Multiplex Detection Immunoassay Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Technique
    • 8.2.4. By Technology
    • 8.2.5. By Application
    • 8.2.6. By End User
  • 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Instruments
    • 8.4.2. Kits & Reagents
    • 8.4.3. Software & Services
  • 8.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 8.5.1. Nucleic Acid Multiplex Assays
    • 8.5.2. Protein Multiplex Assays
    • 8.5.3. Cell-Based Multiplex Assays
  • 8.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 8.6.1. Flow Cytometry
    • 8.6.2. Multiplex Bead-Based Assay
    • 8.6.3. Luminescence
    • 8.6.4. Multiplex Real-Time PCR
    • 8.6.5. Others
  • 8.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.7.1. Disease Diagnostics
    • 8.7.2. Research & Development
    • 8.7.3. Drug Discovery & Development
    • 8.7.4. Others
  • 8.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.8.1. Pharmaceutical & Biotech Companies
    • 8.8.2. Clinical Research Organizations (CROs)
    • 8.8.3. Academic Research Institutes
    • 8.8.4. Diagnostic and Reference Laboratories
    • 8.8.5. Others
  • 8.9. Market Attractiveness Analysis

9. East Asia Multiplex Detection Immunoassay Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Technique
    • 9.2.4. By Technology
    • 9.2.5. By Application
    • 9.2.6. By End User
  • 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Instruments
    • 9.4.2. Kits & Reagents
    • 9.4.3. Software & Services
  • 9.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 9.5.1. Nucleic Acid Multiplex Assays
    • 9.5.2. Protein Multiplex Assays
    • 9.5.3. Cell-Based Multiplex Assays
  • 9.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 9.6.1. Flow Cytometry
    • 9.6.2. Multiplex Bead-Based Assay
    • 9.6.3. Luminescence
    • 9.6.4. Multiplex Real-Time PCR
    • 9.6.5. Others
  • 9.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.7.1. Disease Diagnostics
    • 9.7.2. Research & Development
    • 9.7.3. Drug Discovery & Development
    • 9.7.4. Others
  • 9.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.8.1. Pharmaceutical & Biotech Companies
    • 9.8.2. Clinical Research Organizations (CROs)
    • 9.8.3. Academic Research Institutes
    • 9.8.4. Diagnostic and Reference Laboratories
    • 9.8.5. Others
  • 9.9. Market Attractiveness Analysis

10. South Asia & Oceania Multiplex Detection Immunoassay Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Technique
    • 10.2.4. By Technology
    • 10.2.5. By Application
    • 10.2.6. By End User
  • 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Instruments
    • 10.4.2. Kits & Reagents
    • 10.4.3. Software & Services
  • 10.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 10.5.1. Nucleic Acid Multiplex Assays
    • 10.5.2. Protein Multiplex Assays
    • 10.5.3. Cell-Based Multiplex Assays
  • 10.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 10.6.1. Flow Cytometry
    • 10.6.2. Multiplex Bead-Based Assay
    • 10.6.3. Luminescence
    • 10.6.4. Multiplex Real-Time PCR
    • 10.6.5. Others
  • 10.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.7.1. Disease Diagnostics
    • 10.7.2. Research & Development
    • 10.7.3. Drug Discovery & Development
    • 10.7.4. Others
  • 10.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.8.1. Pharmaceutical & Biotech Companies
    • 10.8.2. Clinical Research Organizations (CROs)
    • 10.8.3. Academic Research Institutes
    • 10.8.4. Diagnostic and Reference Laboratories
    • 10.8.5. Others
  • 10.9. Market Attractiveness Analysis

11. Latin America Multiplex Detection Immunoassay Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Technique
    • 11.2.4. By Technology
    • 11.2.5. By Application
    • 11.2.6. By End User
  • 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Instruments
    • 11.4.2. Kits & Reagents
    • 11.4.3. Software & Services
  • 11.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 11.5.1. Nucleic Acid Multiplex Assays
    • 11.5.2. Protein Multiplex Assays
    • 11.5.3. Cell-Based Multiplex Assays
  • 11.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 11.6.1. Flow Cytometry
    • 11.6.2. Multiplex Bead-Based Assay
    • 11.6.3. Luminescence
    • 11.6.4. Multiplex Real-Time PCR
    • 11.6.5. Others
  • 11.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.7.1. Disease Diagnostics
    • 11.7.2. Research & Development
    • 11.7.3. Drug Discovery & Development
    • 11.7.4. Others
  • 11.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.8.1. Pharmaceutical & Biotech Companies
    • 11.8.2. Clinical Research Organizations (CROs)
    • 11.8.3. Academic Research Institutes
    • 11.8.4. Diagnostic and Reference Laboratories
    • 11.8.5. Others
  • 11.9. Market Attractiveness Analysis

12. Middle East & Africa Multiplex Detection Immunoassay Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Technique
    • 12.2.4. By Technology
    • 12.2.5. By Application
    • 12.2.6. By End User
  • 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Instruments
    • 12.4.2. Kits & Reagents
    • 12.4.3. Software & Services
  • 12.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 12.5.1. Nucleic Acid Multiplex Assays
    • 12.5.2. Protein Multiplex Assays
    • 12.5.3. Cell-Based Multiplex Assays
  • 12.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 12.6.1. Flow Cytometry
    • 12.6.2. Multiplex Bead-Based Assay
    • 12.6.3. Luminescence
    • 12.6.4. Multiplex Real-Time PCR
    • 12.6.5. Others
  • 12.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.7.1. Disease Diagnostics
    • 12.7.2. Research & Development
    • 12.7.3. Drug Discovery & Development
    • 12.7.4. Others
  • 12.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.8.1. Pharmaceutical & Biotech Companies
    • 12.8.2. Clinical Research Organizations (CROs)
    • 12.8.3. Academic Research Institutes
    • 12.8.4. Diagnostic and Reference Laboratories
    • 12.8.5. Others
  • 12.9. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Meridian Bioscience
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Thermo Fisher Scientific Inc.
    • 13.3.3. Bio-Rad Laboratories, Inc.
    • 13.3.4. QIAGEN
    • 13.3.5. Bio-Techne
    • 13.3.6. DiaSorin S.p.A.
    • 13.3.7. BIOMERIEUX
    • 13.3.8. Quanterix
    • 13.3.9. Randox Laboratories Ltd.
    • 13.3.10. Merck KGaA
    • 13.3.11. Revvity
    • 13.3.12. F. Hoffmann-La Roche Ltd
    • 13.3.13. Sartorius AG
    • 13.3.14. Seegene Inc.
    • 13.3.15. BioGenex
    • 13.3.16. Miltenyi Biotec
    • 13.3.17. SouthernBiotech
    • 13.3.18. Healgen
    • 13.3.19. Sepmag
    • 13.3.20. Curiox Biosystems
    • 13.3.21. MESO SCALE DIAGNOSTICS, LLC
    • 13.3.22. Wuxi NEST Biotechnology Co.,Ltd

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations